Caitlyn Stulpin
- Indexed articles, last 90 days
- 6
- Latest publication
- Sep 28, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Aug 20, 2026
Latest articles
E. coli outbreak in 9 states linked to raw milk cheese (opens the original)
Read excerpt
The CDC and FDA are investigating a multistate Escherichia coli outbreak linked to recalled raw milk cheeses. The ongoing outbreak has sickened 13 people in nine states — California, Colorado, Georgia, Kentucky, Michigan, Nevada, Oregon, Tennessee and Utah. Eight people have been hospitalized, three of whom developed hemolytic uremic syndrome, a serious complication of Shiga toxin-producing E. coli (STEC) infection that can lead to various health conditions or even death, according to the CDC. M
Survey: Adults supportive of vaccines often miss shots because of confusion (opens the original)
Read excerpt
Despite supporting vaccines, many U.S. adults forgo shots for influenza and other respiratory diseases because they are unclear about the recommendations, according to survey results released Thursday. “Last year’s respiratory season was another reminder that these illnesses — flu, COVID-19, RSV and pneumococcal disease — while often common, are not always mild,” Robert H. Hopkins, Jr., MD, medical director of the National Foundation for Infectious Diseases (NFID), said during the organization’s
Expert urges caution despite âencouraging signsâ in Ebola outbreak (opens the original)
Read excerpt
There has been some recent optimism that the Ebola virus outbreak in the Democratic Republic of the Congo may have slowed after spreading faster than any other outbreak on record. “We’re now starting to see encouraging signs that we’re gaining ground,” WHO Director-General Tedros Adhanom Ghebreyesus, PhD, MSc, said in a press conference last week. “In the most affected parts of the Ituri province, transmission is going down.” The outbreak is being caused by the relatively rare Bundibugyo species
Trial backs use of lenacapavir for pregnant, postpartum women (opens the original)
Read excerpt
Data from a phase 3 study assessing more than 5,000 women and 500 pregnancies support the use of long-acting lenacapavir as HIV pre-exposure prophylaxis among pregnant, postpartum and lactating women, researchers said. Lenacapavir (Yeztugo, Gilead) is administered via two injections given every 6 months. It has been approved for treatment in the United States for people with drug-resistant HIV since 2022, and for HIV PrEP since 2025. PURPOSE 1 was landmark phase 3 trial conducted among cisgender
Does U = U apply to breastfeeding with HIV? (opens the original)
Read excerpt
With “Undetectable = Untransmittable,” or U = U, the message is clear: People with HIV who maintain an undetectable viral load on treatment cannot sexually transmit the virus to people without HIV. The longstanding U = U awareness campaign, which spotlights the effectiveness of modern HIV medications, has roots that go back a decade. This message, however, is more nuanced when it comes to breastfeeding with HIV. In an editorial published in The Lancet HIV, Dvora Joseph Davey, PhD, an infectious
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.